Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 21 April 2009
Vol. 2, Issue 67, p. pc8
Science Signaling Podcast: 21 April 2009
Michael B. Yaffe1,2 and
Annalisa M. VanHook3
1 Chief Scientific Editor of Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA. 2 David H. Koch Institute for Integrative Cancer Research, Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. 3Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.
This is a conversation with Michael Yaffe, Chief Scientific Editor of Science Signaling. He discusses signaling through the mammalian target of rapamycin (mTOR) pathway, the topic of a Science Signaling Focus Issue released this week.
Citation: M. B. Yaffe, A. M. VanHook, Science Signaling Podcast: 21 April 2009. Sci. Signal.2, pc8 (2009).
Caterina Nardella, Arkaitz Carracedo, Andrea Alimonti, Robin M. Hobbs, John G. Clohessy, Zhenbang Chen, Ainara Egia, Alessandro Fornari, Michelangelo Fiorentino, Massimo Loda, Sara C. Kozma, George Thomas, Carlos Cordon-Cardo, and Pier Paolo Pandolfi (27 January 2009) Sci. Signal.2 (55), ra2.
[DOI: 10.1126/scisignal.2000189] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »